From Casetext: Smarter Legal Research

King Drug Co. of Florence, Inc. v. SmithKline Beecham Corp.

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT
Sep 23, 2015
No. 14-1243 (3d Cir. Sep. 23, 2015)

Opinion

No. 14-1243

09-23-2015

KING DRUG COMPANY OF FLORENCE, INC.; LOUISIANA WHOLESALE DRUG CO., INC., on behalf of itself and all others similarly situated, Appellants v. SMITHKLINE BEECHAM CORPORATION, doing business as GLAXOSMITHKLINE; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS


On Appeal from the United States District Court for the District of New Jersey
D.C. Civil Action No. 2-12-cv-00995
District Judge: Honorable William H. Walls
Before: AMBRO, SCIRICA, and ROTH, Circuit Judges ORDER AMENDING OPINION

The Precedential Opinion which was filed on June 26, 2015 shall be amended with respect to footnote 27 which appears on page 37 of the opinion. The footnote as amended shall read in its entirety:

27. We do not believe that the no-AG agreement was in fact an "exclusive" license. However, since the issue of whether such agreement is an exclusive license is not necessary for our decision here, we will leave its determination for another day.
This amendment does not alter the original filing date of the opinion and the Court's judgment.

By the Court,

s/ Anthony J. Scirica

Circuit Judge
Date: September 23, 2015


Summaries of

King Drug Co. of Florence, Inc. v. SmithKline Beecham Corp.

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT
Sep 23, 2015
No. 14-1243 (3d Cir. Sep. 23, 2015)
Case details for

King Drug Co. of Florence, Inc. v. SmithKline Beecham Corp.

Case Details

Full title:KING DRUG COMPANY OF FLORENCE, INC.; LOUISIANA WHOLESALE DRUG CO., INC.…

Court:UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT

Date published: Sep 23, 2015

Citations

No. 14-1243 (3d Cir. Sep. 23, 2015)